Insight into continuous glucose monitoring: from medical basics to commercialized devices.
Artificial intelligence
Biosensor
Continuous glucose monitoring
Diabetes
Journal
Mikrochimica acta
ISSN: 1436-5073
Titre abrégé: Mikrochim Acta
Pays: Austria
ID NLM: 7808782
Informations de publication
Date de publication:
06 04 2023
06 04 2023
Historique:
received:
13
12
2022
accepted:
08
03
2023
medline:
10
4
2023
entrez:
6
4
2023
pubmed:
7
4
2023
Statut:
epublish
Résumé
According to the latest statistics, more than 537 million people around the world struggle with diabetes and its adverse consequences. As well as acute risks of hypo- or hyper- glycemia, long-term vascular complications may occur, including coronary heart disease or stroke, as well as diabetic nephropathy leading to end-stage disease, neuropathy or retinopathy. Therefore, there is an urgent need to improve diabetes management to reduce the risk of complications but also to improve patient's quality life. The impact of continuous glucose monitoring (CGM) is well recognized, in this regard. The current review aims at introducing the basic principles of glucose sensing, including electrochemical and optical detection, summarizing CGM technology, its requirements, advantages, and disadvantages. The role of CGM systems in the clinical diagnostics/personal testing, difficulties in their utilization, and recommendations are also discussed. In the end, challenges and prospects in future CGM systems are discussed and non-invasive, wearable glucose biosensors are introduced. Though the scope of this review is CGMs and provides information about medical issues and analytical principles, consideration of broader use will be critical in future if the right systems are to be selected for effective diabetes management.
Identifiants
pubmed: 37022500
doi: 10.1007/s00604-023-05743-w
pii: 10.1007/s00604-023-05743-w
doi:
Substances chimiques
Blood Glucose
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
177Subventions
Organisme : Polish National Agency for Academic Exchange
ID : PPN/BFR/2020/1/00052
Organisme : Campus France
ID : PARTENARIAT HUBERT CURIEN (PHC) Polonium grant 2021
Organisme : Institut Carnot LSI
ID : BIOEPC 2022 project
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Références
International Diabetes Federation (2021) IDF Diabetes Atlas 10th edition.
Gregory GA, Robinson TIG, Linklater SE et al (2022) Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol 10:741–760. https://doi.org/10.1016/S2213-8587(22)00218-2
doi: 10.1016/S2213-8587(22)00218-2
pubmed: 36113507
Marcon LMR, Fanelli CG, Calafiore R (2022) Type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA): the difference between a honeymoon and a holiday. Case Rep Endocrinol 9363543:1–5. https://doi.org/10.1155/2022/9363543
doi: 10.1155/2022/9363543
Erlich H, Valdes AM, Noble J et al (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk analysis of the type 1 diabetes genetics consortium families. Diabetes 57:1084–1092. https://doi.org/10.2337/db07-1331
doi: 10.2337/db07-1331
pubmed: 18252895
Yoo EH, Lee SY (2010) Glucose biosensors: an overview of use in clinical practice. Sensors 10:4558–4576
doi: 10.3390/s100504558
pubmed: 22399892
pmcid: 3292132
Davies MJ, D’Alessio DA, Fradkin J et al (2018) Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 61:2461–2498. https://doi.org/10.1007/s00125-018-4729-5
doi: 10.1007/s00125-018-4729-5
pubmed: 30288571
Fralick M, Jenkins AJ, Khunti K et al (2022) Global accessibility of therapeutics for diabetes mellitus. Nat Rev Endocrinol 18:199–204. https://doi.org/10.1038/s41574-021-00621-y
doi: 10.1038/s41574-021-00621-y
pubmed: 35039662
pmcid: 8762447
Reifsnider OS, Pimple P, Brand S et al (2022) Cost-effectiveness of second-line empagliflozin versus liraglutide for type 2 diabetes in the United States. Diabetes Obes Metab 24:652–661. https://doi.org/10.1111/dom.14625
doi: 10.1111/dom.14625
pubmed: 34910356
pmcid: 9305296
Yang W, Dall TM, Beronjia K et al (2018) Economic costs of diabetes in the U.S. in 2017. Diabetes Care 41:917–928. https://doi.org/10.2337/dci18-0007
doi: 10.2337/dci18-0007
Walta AM, Keltanen T, Lindroos K, Sajantila A (2016) The usefulness of point-of-care (POC) tests in screening elevated glucose and ketone body levels postmortem. Forensic Sci Int 266:299–303. https://doi.org/10.1016/j.forsciint.2016.06.003
doi: 10.1016/j.forsciint.2016.06.003
pubmed: 27348467
Lu M, Zuo Y, Guo J et al (2018) Continuous glucose monitoring system can improve the quality of glucose control and glucose variability compared with point-of-care measurement in critically ill patients: a randomized controlled trial. Medicine (United States) 97:e12138. https://doi.org/10.1097/MD.0000000000012138
doi: 10.1097/MD.0000000000012138
Montagnana M, Caputo M, Giavarina D, Lippi G (2009) Overview on self-monitoring of blood glucose. Clin Chim Acta 402:7–13. https://doi.org/10.1016/j.cca.2009.01.002
doi: 10.1016/j.cca.2009.01.002
pubmed: 19167374
Pullano SA, Greco M, Bianco MG et al (2022) Glucose biosensors in clinical practice: principles, limits and perspectives of currently used devices. Theranostics 12:493–511. https://doi.org/10.7150/thno.64035
doi: 10.7150/thno.64035
pubmed: 34976197
pmcid: 8692922
Chehregosha H, Khamseh ME, Malek M et al (2019) A view beyond HbA1c: role of continuous glucose monitoring. Diabetes Therapy 10:853–863. https://doi.org/10.1007/s13300-019-0619-1
doi: 10.1007/s13300-019-0619-1
pubmed: 31037553
pmcid: 6531520
Piona C, Marigliano M, Mozzillo E et al (2021) Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 177:108933. https://doi.org/10.1016/j.diabres.2021.108933
doi: 10.1016/j.diabres.2021.108933
pubmed: 34216681
Wang J (2008) Electrochemical glucose biosensors. Chem Rev 108:814–825
doi: 10.1021/cr068123a
pubmed: 18154363
Bolinder J, Antuna R, Geelhoed-Duijvestijn P et al (2016) Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. The Lancet 388:2254–2263. https://doi.org/10.1016/S0140-6736(16)31535-5
doi: 10.1016/S0140-6736(16)31535-5
Beck RW, Riddlesworth T, Ruedy K et al (2017) Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections. JAMA 317:371. https://doi.org/10.1001/jama.2016.19975
doi: 10.1001/jama.2016.19975
pubmed: 28118453
Dunn TC, Xu Y, Hayter G, Ajjan RA (2018) Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: a European analysis of over 60 million glucose tests. Diabetes Res Clin Pract 137:37–46. https://doi.org/10.1016/j.diabres.2017.12.015
doi: 10.1016/j.diabres.2017.12.015
pubmed: 29278709
Benhamou PY, Franc S, Reznik Y et al (2019) Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial. Lancet Digit Health 1:e17–e25. https://doi.org/10.1016/S2589-7500(19)30003-2
doi: 10.1016/S2589-7500(19)30003-2
pubmed: 33323237
Marling CR, Struble NW, Bunescu RC et al (2013) A consensus perceived glycemic variability metric. J Diabetes Sci Technol 7:871–879. https://doi.org/10.1177/193229681300700409
doi: 10.1177/193229681300700409
pubmed: 23911168
pmcid: 3879751
Bruen D, Delaney C, Florea L, Diamond D (2017) Glucose sensing for diabetes monitoring: recent developments. Sensors 17:1866. https://doi.org/10.3390/s17081866
doi: 10.3390/s17081866
pubmed: 28805693
pmcid: 5579887
Sun M, Pei X, Xin T et al (2022) A flexible microfluidic chip-based universal fully integrated nanoelectronic system with point-of-care raw sweat, tears, or saliva glucose monitoring for potential noninvasive glucose management. Anal Chem 94:1890–1900. https://doi.org/10.1021/acs.analchem.1c05174
doi: 10.1021/acs.analchem.1c05174
pubmed: 35006672
Roglic G, Norris SL (2018) Medicines for treatment intensification in type 2 diabetes and type of insulin in type 1 and type 2 diabetes in low-resource settings: synopsis of the World Health Organization Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in nonpregnant adults with diabetes mellitus. Ann Intern Med 169:394. https://doi.org/10.7326/M18-1149
doi: 10.7326/M18-1149
pubmed: 30178023
Ramondetti F, Sacco S, Comelli M et al (2012) Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry. Diabet Med 29:761–766. https://doi.org/10.1111/j.1464-5491.2011.03529.x
doi: 10.1111/j.1464-5491.2011.03529.x
pubmed: 22133003
Korkmaz HA, Ermiş Ç (2019) A case of immune-mediated type 1 diabetes mellitus due to congenital rubella infection. Ann Pediatr Endocrinol Metab 24:68–70. https://doi.org/10.6065/apem.2019.24.1.68
doi: 10.6065/apem.2019.24.1.68
pubmed: 30943684
pmcid: 6449622
Ikegami H, Babaya N, Noso S (2021) β-Cell failure in diabetes: common susceptibility and mechanisms shared between type 1 and type 2 diabetes. J Diabetes Investig 12:1526–1539. https://doi.org/10.1111/jdi.13576
doi: 10.1111/jdi.13576
pubmed: 33993642
pmcid: 8409822
Oguz A, Sahin M, Tuzun D et al (2021) Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: a cross-sectional study. Medicine 100:e26529. https://doi.org/10.1097/MD.0000000000026529
doi: 10.1097/MD.0000000000026529
pubmed: 34190188
pmcid: 8257893
Simonson DC, Hu B, Arterburn DE et al (2022) Alliance of randomized trials of medicine vs metabolic surgery in type 2 diabetes (ARMMS-T2D): study rationale, design, and methods. Diabetes Obes Metab 24:1206–1215. https://doi.org/10.1111/dom.14680
doi: 10.1111/dom.14680
pubmed: 35233923
Liu Z, Zhang Y, Graham S et al (2020) Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. J Hepatol 73:263–276. https://doi.org/10.1016/j.jhep.2020.03.006
doi: 10.1016/j.jhep.2020.03.006
pubmed: 32165250
pmcid: 7371536
Razzak RA, Alshaiji AF, Qareeballa AA, et al (2018) High-normal blood glucose levels may be associated with decreased spatial perception in young healthy adults. PLoS One 13:. https://doi.org/10.1371/journal.pone.0199051
Yang G, Li C, Gong Y, et al (2016) Assessment of insulin resistance in subjects with normal glucose tolerance, hyperinsulinemia with normal blood glucose tolerance, impaired glucose tolerance, and newly diagnosed type 2 diabetes (prediabetes insulin resistance research). J Diabetes Res 2016. https://doi.org/10.1155/2016/9270768
Jara AJ, Zamora MA, Skarmeta AFG (2011) An Internet of things-based personal device for diabetes therapy management in ambient assisted living (AAL). Pers Ubiquitous Comput 15:431–440. https://doi.org/10.1007/s00779-010-0353-1
doi: 10.1007/s00779-010-0353-1
Maruthur NM, Tseng E, Hutfless S et al (2016) Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes. Ann Intern Med 164:740. https://doi.org/10.7326/M15-2650
doi: 10.7326/M15-2650
pubmed: 27088241
Herman A, Aerts O, Baeck M et al (2017) Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensor. Contact Dermatitis 77:367–373. https://doi.org/10.1111/cod.12866
doi: 10.1111/cod.12866
pubmed: 28804907
Karpova EV, Shcherbacheva EV, Galushin A, Vokhmyanina DV, Karyakina E, Karyakin A (2019) Noninvasive diabetes monitoring through continuous analysis of sweat using flow-through glucose biosensor. Anal Chem 91:3778–3783. https://doi.org/10.1021/acs.analchem.8b05928
doi: 10.1021/acs.analchem.8b05928
pubmed: 30773009
Blüher M (2014) Adipokines – removing road blocks to obesity and diabetes therapy. Mol Metab 3:230–240. https://doi.org/10.1016/j.molmet.2014.01.005
doi: 10.1016/j.molmet.2014.01.005
pubmed: 24749053
pmcid: 3986498
Muda R, Sawicki P, Ginszt M (2021) Perceived food palatability, blood glucose level and future discounting: lack of evidence for blood glucose level’s impact on reward discounting. PLoS One 16. https://doi.org/10.1371/journal.pone.0255484
Husdal R, Thors Adolfsson E, Leksell J, Nordgren L (2021) Diabetes care provided by national standards can improve patients’ self-management skills: a qualitative study of how people with type 2 diabetes perceive primary diabetes care. Health Expect 24:1000–1008. https://doi.org/10.1111/hex.13247
doi: 10.1111/hex.13247
pubmed: 33774899
pmcid: 8235889
Heo YJ, Takeuchi S (2013) Towards smart tattoos: implantable biosensors for continuous glucose monitoring. Adv Healthc Mater 2:43–56. https://doi.org/10.1002/adhm.201200167
doi: 10.1002/adhm.201200167
pubmed: 23184404
Noakes TD (2022) What is the evidence that dietary macronutrient composition influences exercise performance? A narrative review Nutrients 14:862. https://doi.org/10.3390/nu14040862
doi: 10.3390/nu14040862
pubmed: 35215511
Storey HL, van Pelt MH, Bun S et al (2018) Diagnostic accuracy of self-administered urine glucose test strips as a diabetes screening tool in a low-resource setting in Cambodia. BMJ Open 8:e019924. https://doi.org/10.1136/bmjopen-2017-019924
doi: 10.1136/bmjopen-2017-019924
pubmed: 29567849
pmcid: 5875619
Dallosso HM, Bodicoat DH, Campbell M et al (2015) Self-monitoring of blood glucose versus self-monitoring of urine glucose in adults with newly diagnosed Type 2 diabetes receiving structured education: a cluster randomized controlled trial. Diabet Med 32:414–422. https://doi.org/10.1111/dme.12598
doi: 10.1111/dme.12598
pubmed: 25308625
Müller N, Kämmer K, Kloos C et al (2015) Postprandial self-monitoring of urine glucose reflects glycaemic control in people with relatively well controlled Type 2 diabetes mellitus not treated with insulin: a retrospective cohort study. Diabet Med 32:958–962. https://doi.org/10.1111/dme.12718
doi: 10.1111/dme.12718
pubmed: 25659184
Aakre KM, Watine J, Bunting PS et al (2012) Self-monitoring of blood glucose in patients with diabetes who do not use insulin-are guidelines evidence-based? Diabet Med 29:1226–1236. https://doi.org/10.1111/j.1464-5491.2012.03659.x
doi: 10.1111/j.1464-5491.2012.03659.x
pubmed: 22435892
Suh S, Kim JH (2015) Glycemic variability: how do we measure it and why is it important? Diabetes Metab J 39:273. https://doi.org/10.4093/dmj.2015.39.4.273
doi: 10.4093/dmj.2015.39.4.273
pubmed: 26301188
pmcid: 4543190
Kraaijeveld SR (2021) Continuous glucose monitoring as a matter of justice. HEC Forum 33:345–370. https://doi.org/10.1007/s10730-020-09413-9
doi: 10.1007/s10730-020-09413-9
pubmed: 32440803
Caduff A, Lutz HU, Heinemann L et al (2011) Dynamics of blood electrolytes in repeated hyper-and/or hypoglycaemic events in patients with type 1 diabetes. Diabetologia 54:2678–2689. https://doi.org/10.1007/s00125-011-2210-9
doi: 10.1007/s00125-011-2210-9
pubmed: 21674178
Alfadhly A, Darraj H, Alamlki B et al (2022) Hyperglycaemic and hypoglycaemic emergencies among patients with diabetes mellitus who participated in pilgrims of the 2019/1440H Hajj season. J Family Med Prim Care 11:312. https://doi.org/10.4103/jfmpc.jfmpc_1096_21
doi: 10.4103/jfmpc.jfmpc_1096_21
pubmed: 35309661
pmcid: 8930157
de la Paz E, Barfidokht A, Rios S et al (2021) Extended noninvasive glucose monitoring in the interstitial fluid using an epidermal biosensing patch. Anal Chem 93:12767–12775. https://doi.org/10.1021/acs.analchem.1c02887
doi: 10.1021/acs.analchem.1c02887
pubmed: 34477377
Fried DA, Fried R (2020) Can type 2 diabetes sufferers actually estimate serum glucose level from interstitial fluid glucose level: a diabetes patient’s experience. J Patient Exp 7:307–310. https://doi.org/10.1177/2374373519847384
doi: 10.1177/2374373519847384
pubmed: 32821788
Voskanyan G, Keenan DB, Mastrototaro JJ, Steil GM (2007) Putative delays in interstitial fluid (ISF) glucose kinetics can be attributed to the glucose sensing systems used to measure them rather than the delay in ISF glucose itself. J Diabetes Sci Technol 1:639–644. https://doi.org/10.1177/193229680700100507
doi: 10.1177/193229680700100507
pubmed: 19885132
pmcid: 2769670
Cengiz E, Tamborlane WV (2009) A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther 11:S-11-S−16. https://doi.org/10.1089/dia.2009.0002
doi: 10.1089/dia.2009.0002
Keenan DB, Mastrototaro JJ, Voskanyan G, Steil GM (2009) Delays in minimally invasive continuous glucose monitoring devices: a review of current technology. J Diabetes Sci Technol 3:1207–1214. https://doi.org/10.1177/193229680900300528
doi: 10.1177/193229680900300528
pubmed: 20144438
pmcid: 2769894
Ma K, Yuen JM, Shah NC et al (2011) In vivo, transcutaneous glucose sensing using surface-enhanced spatially offset raman spectroscopy: multiple rats, improved hypoglycemic accuracy, low incident power, and continuous monitoring for greater than 17 days. Anal Chem 83:9146–9152. https://doi.org/10.1021/ac202343e
doi: 10.1021/ac202343e
pubmed: 22007689
pmcid: 3229825
Bhide A, Muthukumar S, Prasad S (2018) CLASP (Continuous lifestyle awareness through sweat platform): a novel sensor for simultaneous detection of alcohol and glucose from passive perspired
Munje RD, Muthukumar S, Prasad S (2017) Lancet-free and label-free diagnostics of glucose in sweat using zinc oxide based flexible bioelectronics. Sens Actuators B Chem 238:482–490. https://doi.org/10.1016/j.snb.2016.07.088
doi: 10.1016/j.snb.2016.07.088
Bhide A, Muthukumar S, Saini A, Prasad S (2018) Simultaneous lancet-free monitoring of alcohol and glucose from low-volumes of perspired human sweat. Sci Rep 8:6507. https://doi.org/10.1038/s41598-018-24543-4
doi: 10.1038/s41598-018-24543-4
pubmed: 29695724
pmcid: 5916883
Hong YJ, Lee H, Kim J, et al (2018) Multifunctional wearable system that integrates sweat-based sensing and vital-sign monitoring to estimate pre-/post-exercise glucose levels. Adv Funct Mater 28:. https://doi.org/10.1002/adfm.201805754
Gao N, Cai Z, Chang G, He Y (2023) Non-invasive and wearable glucose biosensor based on gel electrolyte for detection of human sweat. J Mater Sci 58:890–901. https://doi.org/10.1007/s10853-022-08095-7
doi: 10.1007/s10853-022-08095-7
Baca JT, Finegold DN, Asher SA (2007) Tear glucose analysis for the noninvasive detection and monitoring of diabetes mellitus. Ocul Surf 5:280–293. https://doi.org/10.1016/S1542-0124(12)70094-0
doi: 10.1016/S1542-0124(12)70094-0
pubmed: 17938838
Badugu R, Lakowicz JR, Geddes CD (2005) A glucose-sensing contact lens: from bench top to patient. Curr Opin Biotechnol 16:100–107. https://doi.org/10.1016/j.copbio.2004.12.007
doi: 10.1016/j.copbio.2004.12.007
pubmed: 15722022
pmcid: 4894302
Duong HD, Sohn O-J, Rhee J, il, (2020) Development of a ratiometric fluorescent glucose sensor using an oxygen-sensing membrane immobilized with glucose oxidase for the detection of glucose in tears. Biosensors (Basel) 10:86. https://doi.org/10.3390/bios10080086
doi: 10.3390/bios10080086
pubmed: 32751236
Badugu R, Lakowicz JR, Geddes CD (2004) Noninvasive continuous monitoring of physiological glucose using a monosaccharide-sensing contact lens. Anal Chem 76:610–618. https://doi.org/10.1021/ac0303721
doi: 10.1021/ac0303721
pubmed: 14750854
pmcid: 6906081
Ruan J-L, Chen C, Shen J-H et al (2017) A gelated colloidal crystal attached lens for noninvasive continuous monitoring of tear glucose. Polymers (Basel) 9:125. https://doi.org/10.3390/polym9040125
doi: 10.3390/polym9040125
pubmed: 30970805
Lee W-C, Koh EH, Kim D-H et al (2021) Plasmonic contact lens materials for glucose sensing in human tears. Sens Actuators B Chem 344:130297. https://doi.org/10.1016/j.snb.2021.130297
doi: 10.1016/j.snb.2021.130297
Hu Y, Jiang X, Zhang L et al (2013) Construction of near-infrared photonic crystal glucose-sensing materials for ratiometric sensing of glucose in tears. Biosens Bioelectron 48:94–99. https://doi.org/10.1016/j.bios.2013.03.082
doi: 10.1016/j.bios.2013.03.082
pubmed: 23651573
Liao Y, Yao Y, Lingley A, Parviz B, Otis B (2012) A 3-$\mu\hbox{W}$ CMOS Glucose sensor for wireless contact-lens tear glucose monitoring, Computer Science IEEE Journal of Solid-State Circuits
Cui Y, Zhang H, Zhu J et al (2022) Correlations of salivary and blood glucose levels among six saliva collection methods. Int J Environ Res Public Health 19:4122. https://doi.org/10.3390/ijerph19074122
doi: 10.3390/ijerph19074122
pubmed: 35409805
pmcid: 8999001
Jurysta C, Bulur N, Oguzhan B et al (2009) Salivary glucose concentration and excretion in normal and diabetic subjects. J Biomed Biotechnol 2009:1–6. https://doi.org/10.1155/2009/430426
doi: 10.1155/2009/430426
Zhang W, Du Y, Wang ML (2015) Noninvasive glucose monitoring using saliva nano-biosensor. Sens Biosensing Res 4:23–29. https://doi.org/10.1016/j.sbsr.2015.02.002
doi: 10.1016/j.sbsr.2015.02.002
Arakawa T, Kuroki Y, Nitta H et al (2016) Mouthguard biosensor with telemetry system for monitoring of saliva glucose: a novel cavitas sensor. Biosens Bioelectron 84:106–111. https://doi.org/10.1016/j.bios.2015.12.014
doi: 10.1016/j.bios.2015.12.014
pubmed: 26725934
Chen J, Zhu X, Ju Y et al (2019) Electrocatalytic oxidation of glucose on bronze for monitoring of saliva glucose using a smart toothbrush. Sens Actuators B Chem 285:56–61. https://doi.org/10.1016/j.snb.2019.01.017
doi: 10.1016/j.snb.2019.01.017
Adeniyi O, Nwahara N, Mwanza D et al (2021) Nanohybrid electrocatalyst based on cobalt phthalocyanine-carbon nanotube-reduced graphene oxide for ultrasensitive detection of glucose in human saliva. Sens Actuators B Chem 348:130723. https://doi.org/10.1016/j.snb.2021.130723
doi: 10.1016/j.snb.2021.130723
Machado A, Maneiras R, Bordalo AA, Mesquita RBR (2018) Monitoring glucose, calcium, and magnesium levels in saliva as a non-invasive analysis by sequential injection multi-parametric determination. Talanta 186:192–199. https://doi.org/10.1016/j.talanta.2018.04.055
doi: 10.1016/j.talanta.2018.04.055
pubmed: 29784349
Koushki E, Mirzaei Mohammadabadi F, Baedi J, Ghasedi A (2020) The effects of glucose and glucose oxidase on the Uv-vis spectrum of gold nanoparticles: a study on optical biosensor for saliva glucose monitoring. Photodiagnosis Photodyn Ther 30:101771. https://doi.org/10.1016/j.pdpdt.2020.101771
doi: 10.1016/j.pdpdt.2020.101771
pubmed: 32311543
Bollella P, Gorton L, Ludwig R, Antiochia R (2017) A third generation glucose biosensor based on cellobiose dehydrogenase immobilized on a glassy carbon electrode decorated with electrodeposited gold nanoparticles: characterization and application in human saliva. Sensors 17:1912. https://doi.org/10.3390/s17081912
doi: 10.3390/s17081912
pubmed: 28820469
pmcid: 5579551
Nguyen HH, Lee SH, Lee UJ et al (2019) Immobilized enzymes in biosensor applications Materials 12:121. https://doi.org/10.3390/ma12010121
doi: 10.3390/ma12010121
pubmed: 30609693
Chmayssem A, Hauchard D (2015) New detection method for alkylphenol traces in water based on an integrated electrochemical cell sensor. Rev Sci Eau 28:35–40. https://doi.org/10.7202/1030005ar
doi: 10.7202/1030005ar
Hernández-Cruz M, Galán-Vidal CA, Álvarez-Romero GA et al (2017) Behavior of two and three electrode configuration and different mediators in working electrode on development of disposable screen-printing biosensors for determination of free cholesterol. J Mex Chem Soc 57:47–53. https://doi.org/10.29356/jmcs.v57i1.237
doi: 10.29356/jmcs.v57i1.237
Mondal H, Mondal S (2020) Clarke error grid analysis on graph paper and Microsoft Excel. J Diabetes Sci Technol 14:499. https://doi.org/10.1177/1932296819890875
doi: 10.1177/1932296819890875
pubmed: 31777281
Sengupta S, Handoo A, Haq I et al (2022) Clarke error grid analysis for performance evaluation of glucometers in a tertiary care referral hospital. Indian J Clin Biochem 37:199–205. https://doi.org/10.1007/s12291-021-00971-4
doi: 10.1007/s12291-021-00971-4
pubmed: 35463101
Wang H-C, Lee A-R (2015) Recent developments in blood glucose sensors. J Food Drug Anal 23:191–200. https://doi.org/10.1016/j.jfda.2014.12.001
doi: 10.1016/j.jfda.2014.12.001
pubmed: 28911373
pmcid: 9351764
Hassan MH, Vyas C, Grieve B, Bartolo P (2021) Recent advances in enzymatic and non-enzymatic electrochemical glucose sensing. Sensors 21:4672. https://doi.org/10.3390/s21144672
doi: 10.3390/s21144672
pubmed: 34300412
pmcid: 8309655
Soranzo T, ben Tahar A, Chmayssem A, et al (2022) Electrochemical biosensing of glucose based on the enzymatic reduction of glucose. Sensors 22:7105. https://doi.org/10.3390/s22197105
doi: 10.3390/s22197105
pubmed: 36236202
pmcid: 9572614
Tang Z, Louie RF, Lee JH et al (2001) Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testing. Crit Care Med 29:1062–1070. https://doi.org/10.1097/00003246-200105000-00038
doi: 10.1097/00003246-200105000-00038
pubmed: 11378622
Karyakin AA, Gitelmacher OV, Karyakina EE (1995) Prussian blue-based first-generation biosensor. a sensitive amperometric electrode for glucose. Anal Chem 67:2419–2423. https://doi.org/10.1021/ac00110a016
doi: 10.1021/ac00110a016
Chmayssem A, Verplanck N, Tanase CE et al (2021) Development of a multiparametric (bio)sensing platform for continuous monitoring of stress metabolites. Talanta 229:122275. https://doi.org/10.1016/j.talanta.2021.122275
doi: 10.1016/j.talanta.2021.122275
pubmed: 33838777
Chmayssem A, Petit L, Verplanck N et al (2022) Characterization of the impact of classical cell-culture media on the response of electrochemical sensors. Electroanalysis 34:1201–1211. https://doi.org/10.1002/elan.202100534
doi: 10.1002/elan.202100534
Chmayssem A, Tanase CE, Verplanck N et al (2022) New microfluidic system for electrochemical impedance spectroscopy assessment of cell culture performance: design and development of new electrode material. Biosensors (Basel) 12:452. https://doi.org/10.3390/bios12070452
doi: 10.3390/bios12070452
pubmed: 35884254
Luiz de Mattos I (2001) Evaluation of glucose biosensors based on Prussian Blue and lyophilised, crystalline and cross-linked glucose oxidases (CLEC®). Talanta 54:963–974. https://doi.org/10.1016/S0039-9140(01)00367-8
doi: 10.1016/S0039-9140(01)00367-8
pubmed: 18968320
Garjonyte R, Malinauskas A (2000) Amperometric glucose biosensors based on Prussian Blue– and polyaniline–glucose oxidase modified electrodes. Biosens Bioelectron 15:445–451. https://doi.org/10.1016/S0956-5663(00)00101-9
doi: 10.1016/S0956-5663(00)00101-9
pubmed: 11419639
Che X, Yuan R, Chai Y et al (2010) Amperometric glucose biosensor based on Prussian blue-multiwall carbon nanotubes composite and hollow PtCo nanochains. Electrochim Acta 55:5420–5427. https://doi.org/10.1016/j.electacta.2010.04.091
doi: 10.1016/j.electacta.2010.04.091
Ledo A, Fernandes E, Brett CMA, Barbosa RM (2020) Enhanced selectivity and stability of ruthenium purple-modified carbon fiber microelectrodes for detection of hydrogen peroxide in brain tissue. Sens Actuators B Chem 311:127899. https://doi.org/10.1016/j.snb.2020.127899
doi: 10.1016/j.snb.2020.127899
Tian F, Llaudet E, Dale N (2007) Ruthenium purple-mediated microelectrode biosensors based on sol-gel film. Anal Chem 79:6760–6766. https://doi.org/10.1021/ac070822f
doi: 10.1021/ac070822f
pubmed: 17672522
Milton RD, Hickey DP, Abdellaoui S et al (2015) Rational design of quinones for high power density biofuel cells. Chem Sci 6:4867–4875. https://doi.org/10.1039/c5sc01538c
doi: 10.1039/c5sc01538c
pubmed: 28717492
pmcid: 5502403
Scheller FW, Schubert F, Neumann B et al (1991) Second generation biosensors. Biosens Bioelectron 6:245–253. https://doi.org/10.1016/0956-5663(91)80010-U
doi: 10.1016/0956-5663(91)80010-U
pubmed: 1652986
Seiwert B, Karst U (2008) Ferrocene-based derivatization in analytical chemistry. Anal Bioanal Chem 390:181–200. https://doi.org/10.1007/s00216-007-1639-7
doi: 10.1007/s00216-007-1639-7
pubmed: 17934723
Laurinavicius V, Kurtinaitiene B, Liauksminas V et al (1999) Oxygen insensitive glucose biosensor based on PQQ-dependent glucose dehydrogenase. Anal Lett 32:299–316. https://doi.org/10.1080/00032719908542822
doi: 10.1080/00032719908542822
Kausaite-Minkstimiene A, Mazeiko V, Ramanaviciene A et al (2014) Evaluation of some redox mediators in the design of reagentless amperometric glucose biosensor. Electroanalysis 26:1528–1535. https://doi.org/10.1002/elan.201400023
doi: 10.1002/elan.201400023
Silveira CM, Almeida MG (2013) Small electron-transfer proteins as mediators in enzymatic electrochemical biosensors. Anal Bioanal Chem 405:3619–3635. https://doi.org/10.1007/s00216-013-6786-4
doi: 10.1007/s00216-013-6786-4
pubmed: 23430181
Pijanowska DG, Kossakowska A, Torbicz W (2011) Electroconductive polymers in (bio)chemical sensors. Biocybern Biomed Eng 31:43–57. https://doi.org/10.1016/S0208-5216(11)70025-0
doi: 10.1016/S0208-5216(11)70025-0
Di J, Peng S, Shen C et al (2007) One-step method embedding superoxide dismutase and gold nanoparticles in silica sol-gel network in the presence of cysteine for construction of third-generation biosensor. Biosens Bioelectron 23:88–94. https://doi.org/10.1016/j.bios.2007.03.011
doi: 10.1016/j.bios.2007.03.011
pubmed: 17466509
Palmisano F, Zambonin PG, Centonze D, Quinto M (2002) A disposable, reagentless, third-generation glucose biosensor based on overoxidized poly(pyrrole)/tetrathiafulvalene -Tetracyanoquinodimethane composite. Anal Chem 74:5913–5918. https://doi.org/10.1021/ac0258608
doi: 10.1021/ac0258608
pubmed: 12498183
Xu S, Qin X, Zhang X, Zhang C (2015) A third-generation biosensor for hydrogen peroxide based on the immobilization of horseradish peroxidase on a disposable carbon nanotubes modified screen–printed electrode. Microchim Acta 182:1241–1246. https://doi.org/10.1007/s00604-014-1444-x
doi: 10.1007/s00604-014-1444-x
Wadkins RM, Golden JP, Ligler FS (1995) Calibration of biosensor response using simultaneous evanescent wave excitation of cyanine-labeled capture antibodies and antigens. Anal Biochem 232:73–78. https://doi.org/10.1006/abio.1995.9958
doi: 10.1006/abio.1995.9958
pubmed: 8600836
Li H, Dauphin-Ducharme P, Ortega G, Plaxco KW (2017) Calibration-free electrochemical biosensors supporting accurate molecular measurements directly in undiluted whole blood. J Am Chem Soc 139:11207–11213. https://doi.org/10.1021/jacs.7b05412
doi: 10.1021/jacs.7b05412
pubmed: 28712286
pmcid: 6519131
Chaichi MJ, Ehsani M (2016) A novel glucose sensor based on immobilization of glucose oxidase on the chitosan-coated Fe3O4 nanoparticles and the luminol-H2O2-gold nanoparticle chemiluminescence detection system. Sens Actuators B Chem 223:713–722. https://doi.org/10.1016/j.snb.2015.09.125
doi: 10.1016/j.snb.2015.09.125
Kang X, Mai Z, Zou X et al (2007) A novel glucose biosensor based on immobilization of glucose oxidase in chitosan on a glassy carbon electrode modified with gold-platinum alloy nanoparticles/multiwall carbon nanotubes. Anal Biochem 369:71–79. https://doi.org/10.1016/j.ab.2007.07.005
doi: 10.1016/j.ab.2007.07.005
pubmed: 17678866
Donmez S, Arslan F, Sarı N et al (2017) Glucose biosensor based on immobilization of glucose oxidase on a carbon paste electrode modified with microsphere-attached l-glycine. Biotechnol Appl Biochem 64:745–753. https://doi.org/10.1002/bab.1533
doi: 10.1002/bab.1533
pubmed: 27629272
Kondratowicz I, Shalayel I, Nadolska M et al (2022) Impact of lactic acid and genipin concentration on physicochemical and mechanical properties of chitosan membranes. J Polym Environ. https://doi.org/10.1007/s10924-022-02691-z
doi: 10.1007/s10924-022-02691-z
Rauf S, Ihsan A, Akhtar K et al (2006) Glucose oxidase immobilization on a novel cellulose acetate- polymethylmethacrylate membrane. J Biotechnol 121:351–360. https://doi.org/10.1016/j.jbiotec.2005.08.019
doi: 10.1016/j.jbiotec.2005.08.019
pubmed: 16242200
Coulet PR, Gautheron DC (1981) Enzymes immobilized on collagen membranes: a tool for fundamental research and enzyme engineering. J Chromatogr A 215:65–72. https://doi.org/10.1016/S0021-9673(00)81386-2
doi: 10.1016/S0021-9673(00)81386-2
Rodbard D (2017) Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes. Diabetes Technol Ther 19:S25–S37. https://doi.org/10.1089/dia.2017.0035
doi: 10.1089/dia.2017.0035
pubmed: 28585879
Kropff J, DeVries J, Mortellaro M, DeHennis A (2014) Continuous glucose monitoring, future products, and update on worldwide artificial pancreas projects (2016). Performance characterization of an abiotic and fluorescent-based continuous glucose monitoring system in patients with type 1 diabetes. Biosens Bioelectron 61:227–231. https://doi.org/10.1016/j.bios.2014.05.022
doi: 10.1016/j.bios.2014.05.022
Franc S, Benhamou PY, Borot S et al (2021) No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed-loop system for 12 weeks: a post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial. Diabetes Obes Metab 23:2170–2176. https://doi.org/10.1111/dom.14442
doi: 10.1111/dom.14442
pubmed: 34009725
pmcid: 8453744
Knoll C, Peacock S, Wäldchen M, et al (2022) Real‐world evidence on clinical outcomes of people with type 1 diabetes using open‐source and commercial automated insulin dosing systems: A systematic review. Diabetic Medicine 39. https://doi.org/10.1111/dme.14741
Amadou C, Franc S, Huneker E et al (2022) Short course corticosteroid treatment and closed-loop insulin delivery system: the experience of the DBLG1 pre-launch. Diabetes Metab 48:101294. https://doi.org/10.1016/j.diabet.2021.101294
doi: 10.1016/j.diabet.2021.101294
pubmed: 34666166
Soto RJ, Hall JR, Brown MD, Taylor JB, Mark H (2017) Schoenfisch in vivo chemical sensors: role of biocompatibility on performance and utility. Anal Chem 89:276–299
doi: 10.1021/acs.analchem.6b04251
pubmed: 28105839
Scholten K, Meng E (2018) A review of implantable biosensors for closed-loop glucose control and other drug delivery applications. Int J Pharm 544:319–334
doi: 10.1016/j.ijpharm.2018.02.022
pubmed: 29458204
Barfidokht A, Gooding J (2014) Approaches toward allowing electroanalytical devices to be used in biological fluids. Electroanalysis 12:1182–1196
doi: 10.1002/elan.201400097
Kim J, Campbell AS, Esteban-Fernández de Ávila B, Wang J (2019) Wearable biosensors for healthcare monitoring. Nat Biotechnol 37:389–406
doi: 10.1038/s41587-019-0045-y
pubmed: 30804534
pmcid: 8183422
Longo R, Sperling S (2019) Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectrum 32:183–193. https://doi.org/10.2337/ds18-0093
doi: 10.2337/ds18-0093
pubmed: 31462872
pmcid: 6695260
Moser O, Pandis M, Aberer F et al (2019) A head-to-head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot. Diabetes Obes Metab 21:1043–1048. https://doi.org/10.1111/dom.13598
doi: 10.1111/dom.13598
pubmed: 30484947
Klonoff DC, Ahn D, Drincic A (2017) Continuous glucose monitoring: a review of the technology and clinical use. Diabetes Res Clin Pract 133:178–192. https://doi.org/10.1016/j.diabres.2017.08.005
doi: 10.1016/j.diabres.2017.08.005
pubmed: 28965029
Arrieta A, Battelino T, Scaramuzza AE et al (2022) Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: evidence from 12 870 real-world users. Diabetes Obes Metab 24:1370–1379. https://doi.org/10.1111/dom.14714
doi: 10.1111/dom.14714
pubmed: 35403792
pmcid: 9545031
Petrovski G, al Khalaf F, Campbell J, et al (2022) Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI). BMC Endocr Disord 22:80. https://doi.org/10.1186/s12902-022-00996-7
doi: 10.1186/s12902-022-00996-7
pubmed: 35351095
pmcid: 8962027
Petrovski G, al Khalaf F, Campbell J, et al (2022) Successful transitioning children and adolescents with type 1 diabetes from multiple daily injections to advanced hybrid closed-loop system in 10 days: a prospective intervention study on MiniMed 780G system. Acta Diabetol 59:743–746. https://doi.org/10.1007/s00592-022-01851-w
doi: 10.1007/s00592-022-01851-w
pubmed: 35072781
Carlson AL, Mullen DM, Bergenstal RM (2017) Clinical use of continuous glucose monitoring in adults with type 2 diabetes. Diabetes Technol Ther 19:S-4-S−11. https://doi.org/10.1089/dia.2017.0024
doi: 10.1089/dia.2017.0024
Takeishi S, Inoue T (2021) Comparison between glycemic variability values calculated from professional-cgm and glycemic variability values calculated from personal-CGM. J Endocr Soc 5:A330–A330. https://doi.org/10.1210/jendso/bvab048.674
doi: 10.1210/jendso/bvab048.674
Yoo JH, Kim JH (2020) Time in range from continuous glucose monitoring: a novel metric for glycemic control. Diabetes Metab J 44:828–839. https://doi.org/10.4093/dmj.2020.0257
doi: 10.4093/dmj.2020.0257
pubmed: 33389957
pmcid: 7801761
Blumer I (2016) The contemporary role of masked continuous glucose monitoring in a real-time world. J Diabetes Sci Technol 10:790–792. https://doi.org/10.1177/1932296815619182
doi: 10.1177/1932296815619182
pubmed: 26612249
Fantasia KL, Stockman M-C, Ju Z et al (2021) Professional continuous glucose monitoring and endocrinology eConsult for adults with type 2 diabetes in primary care: results of a clinical pilot program. J Clin Transl Endocrinol 24:100254. https://doi.org/10.1016/j.jcte.2021.100254
doi: 10.1016/j.jcte.2021.100254
pubmed: 33898271
pmcid: 8054187
Liebl A, Henrichs HR, Heinemann L et al (2013) Continuous glucose monitoring: evidence and consensus statement for clinical use. J Diabetes Sci Technol 7:500–519. https://doi.org/10.1177/193229681300700227
doi: 10.1177/193229681300700227
pubmed: 23567009
pmcid: 3737652
Rivera-Ávila DA, Esquivel-Lu AI, Salazar-Lozano CR et al (2021) The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes. BMC Endocr Disord 21:79. https://doi.org/10.1186/s12902-021-00742-5
doi: 10.1186/s12902-021-00742-5
pubmed: 33888117
pmcid: 8063407
Aloraynan A, Rassel S, Xu C, Ban D (2022) Machine learning classifiers for noninvasive glucose detection using a single wavelength mid-infrared photoacoustic spectroscopy. Biomed Spectrosc, Microsc Imaging II 121440I:45. https://doi.org/10.1117/12.2627014
doi: 10.1117/12.2627014
Barnard KD, Kropff J, Choudhary P et al (2018) Acceptability of implantable continuous glucose monitoring sensor. J Diabetes Sci Technol 12:634–638. https://doi.org/10.1177/1932296817735123
doi: 10.1177/1932296817735123
pubmed: 28990436
Raviteja KV, Kumar R, Dayal D, Sachdeva N (2019) Clinical efficacy of professional continuous glucose monitoring in improving glycemic control among children with type 1 diabetes mellitus: an open-label randomized control trial. Sci Rep 9:6120. https://doi.org/10.1038/s41598-019-42555-6
doi: 10.1038/s41598-019-42555-6
pubmed: 30992480
pmcid: 6467868
Khor SM, Choi J, Won P, Ko SH (2022) Challenges and strategies in developing an enzymatic wearable sweat glucose biosensor as a practical point-of-care monitoring tool for type ii diabetes. Nanomaterials 12:221. https://doi.org/10.3390/nano12020221
doi: 10.3390/nano12020221
pubmed: 35055239
pmcid: 8781831
American Diabetes Association Professional Practice Committee (2022) Diabetes Technology: Standards of Medical Care in Diabetes — 2022. Diabetes Care 45:S97–S112. https://doi.org/10.2337/dc22-S007
doi: 10.2337/dc22-S007
Grunberger G, Sherr J, Allende M et al (2021) American Association of Clinical Endocrinology Clinical Practice Guideline: the use of advanced technology in the management of persons with diabetes mellitus. Endocr Pract 27:505–537. https://doi.org/10.1016/j.eprac.2021.04.008
doi: 10.1016/j.eprac.2021.04.008
pubmed: 34116789
Borot S, Benhamou PY, Atlan C et al (2018) Practical implementation, education and interpretation guidelines for continuous glucose monitoring: a French position statement. Diabetes Metab 44:61–72. https://doi.org/10.1016/j.diabet.2017.10.009
doi: 10.1016/j.diabet.2017.10.009
pubmed: 29174479
Akturk HK, Dowd R, Shankar K, Derdzinski M (2021) Real-world evidence and glycemic improvement using Dexcom G6 FEATURES. Diabetes Technol Ther 23:S-21-S−26. https://doi.org/10.1089/dia.2020.0654
doi: 10.1089/dia.2020.0654
Mansoor Bai M, Gholam Hosseini H, Gutierrez J, Ullah E, Lindén M (2021) Early detection of prediabetes and T2DM using wearable sensors and internet-of-things-based monitoring applications. Appl Clin Inform 12(01):001–009. https://doi.org/10.1055/s-0040-1719043
doi: 10.1055/s-0040-1719043
Jin X, Liu C, Xu T et al (2020) Artificial intelligence biosensors: challenges and prospects. Biosens Bioelectron 165:112412. https://doi.org/10.1016/j.bios.2020.112412
doi: 10.1016/j.bios.2020.112412
pubmed: 32729531
Mejía-Salazar JR, Rodrigues Cruz K, Materón Vásques EM, de Oliveira ON Jr (2020) Microfluidic point-of-care devices: new trends and future prospects for eHealth diagnostics. Sensors 20:1951. https://doi.org/10.3390/s20071951
doi: 10.3390/s20071951
pubmed: 32244343
pmcid: 7180826
Gopinath SCB, Ismail ZH, Shapiai MI, Sobran NMM (2022) Biosensing human blood clotting factor by dual probes: evaluation by deep long short-term memory networks in time series forecasting. Biotechnol Appl Biochem 69:930–938. https://doi.org/10.1002/bab.2164
doi: 10.1002/bab.2164
pubmed: 33835514
Jiang M, Zheng S, Zhu Z (2022) What can AI-TENG do for low abundance biosensing? Front Bioeng Biotechnol 10:899858. https://doi.org/10.3389/fbioe.2022.899858
doi: 10.3389/fbioe.2022.899858
pubmed: 35600897
pmcid: 9117749
Oliveira ON, Oliveira MCF (2021) Sensing and biosensing in the world of autonomous machines and intelligent systems. Frontiers in Sensors 2:752754. https://doi.org/10.3389/fsens.2021.752754
doi: 10.3389/fsens.2021.752754
Hanaire H, Franc S, Borot S et al (2020) Efficacy of the Diabeloop closed-loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise. Diabetes Obes Metab 22:324–334. https://doi.org/10.1111/dom.13898
doi: 10.1111/dom.13898
pubmed: 31621186
Benhamou PY, Huneker E, Franc S et al (2018) Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop study. Acta Diabetol 55:549–556. https://doi.org/10.1007/s00592-018-1123-1
doi: 10.1007/s00592-018-1123-1
pubmed: 29520615
Poudineh M, Maikawa CL, Yue Ma E, Pan J, Mamerow D, Hang Y, Baker SW, Beirami A, Yoshikawa A, Eisenstein M, Kim S, Vučković J, Appel EA, Soh HT (2021) A fluorescence sandwich immunoassay for the real-time continuous detection of glucose and insulin in live animals. Nat Biomed Eng 5:53–63. https://doi.org/10.1038/s41551-020-00661-1
doi: 10.1038/s41551-020-00661-1
pubmed: 33349659
Chmayssem A, Shalayel I, Marinesco S, Zebda A (2023) Investigation of GOx Stability in a Chitosan Matrix: Applications for Enzymatic Electrodes. Sensors 23(1):465. https://doi.org/10.3390/s23010465
doi: 10.3390/s23010465
pubmed: 36617063
pmcid: 9824325
Matuleviciene V, Joseph J, Andelin M et al (2014) A clinical trial of the accuracy and treatment experience of the Dexcom G4 Sensor (Dexcom G4 System) and enlite sensor (Guardian REAL-Time System) tested simultaneously in ambulatory patients with type 1 diabetes. Diabetes Technol Ther 16:759–767. https://doi.org/10.1089/dia.2014.0238
doi: 10.1089/dia.2014.0238
pubmed: 25233297
pmcid: 4201312
Welsh JB, Gao P, Derdzinski M et al (2019) Accuracy, utilization, and effectiveness comparisons of different continuous glucose monitoring systems. Diabetes Technol Ther 21:128–132. https://doi.org/10.1089/dia.2018.0374
doi: 10.1089/dia.2018.0374
pubmed: 30681379
pmcid: 6434583
Kosiborod M, Gottlieb RK, Sekella JA et al (2014) Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit. BMJ Open Diabetes Res Care 2:e000037. https://doi.org/10.1136/bmjdrc-2014-000037
doi: 10.1136/bmjdrc-2014-000037
pubmed: 25452874
pmcid: 4212554
Calhoun P, Lum J, Beck RW, Kollman C (2013) Performance comparison of the Medtronic Sof-Sensor and Enlite Glucose Sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technol Ther 15:758–761. https://doi.org/10.1089/dia.2013.0042
doi: 10.1089/dia.2013.0042
pubmed: 23725474
pmcid: 3757531
Perrier L (2019) Accessing continuous glucose monitoring (CGM) sensors in France and the US: a comparative case study of abbott’s freestyle libre (FSL) System. J Commer Biotechnol 25:24–39. https://doi.org/10.5912/JCB873
doi: 10.5912/JCB873
Kropff J, Choudhary P, Neupane S et al (2017) Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE study: a 180-day, prospective, multicenter, pivotal trial. Diabetes Care 40:63–68. https://doi.org/10.2337/dc16-1525
doi: 10.2337/dc16-1525
pubmed: 27815290
Christiansen MP, Klaff LJ, Brazg R et al (2018) A prospective multicenter evaluation of the accuracy of a novel implanted continuous glucose sensor: PRECISE II. Diabetes Technol Ther 20:197–206. https://doi.org/10.1089/dia.2017.0142
doi: 10.1089/dia.2017.0142
pubmed: 29381090
pmcid: 5867508
Domingo-Lopez DA, Lattanzi G, Schreiber LHJ et al (2022) Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus. Adv Drug Deliv Rev 185:114280. https://doi.org/10.1016/j.addr.2022.114280
doi: 10.1016/j.addr.2022.114280
pubmed: 35405298
Heinemann L, Schoemaker M, Schmelzeisen-Redecker G et al (2020) Benefits and limitations of MARD as a performance parameter for continuous glucose monitoring in the interstitial space. J Diabetes Sci Technol 14:135–150. https://doi.org/10.1177/1932296819855670
doi: 10.1177/1932296819855670
pubmed: 31216870
Reiterer F, Polterauer P, Schoemaker M et al (2017) Significance and reliability of MARD for the accuracy of CGM systems. J Diabetes Sci Technol 11:59–67. https://doi.org/10.1177/1932296816662047
doi: 10.1177/1932296816662047
pubmed: 27566735
Garg SK, Kipnes M, Castorino K et al (2022) Accuracy and safety of Dexcom G7 continuous glucose monitoring in adults with diabetes. Diabetes Technol Ther 24:373–380. https://doi.org/10.1089/dia.2022.0011
doi: 10.1089/dia.2022.0011
pubmed: 35157505
pmcid: 9208857
Collyns OJ, Meier RA, Betts ZL et al (2021) Improved glycemic outcomes with Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes. Diabetes Care 44:969–975. https://doi.org/10.2337/dc20-2250
doi: 10.2337/dc20-2250
pubmed: 33579715
Carlson AL, Sherr JL, Shulman DI et al (2022) Safety and glycemic outcomes during the MiniMedTM advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes. Diabetes Technol Ther 24:178–189. https://doi.org/10.1089/dia.2021.0319
doi: 10.1089/dia.2021.0319
pubmed: 34694909
pmcid: 8971997
Li Y, Cao B, Chen Q et al (2022) Application of the FreeStyle® Libre glucose monitoring system in type 1 diabetes mellitus patients aged 1–4 years. Pediatr Diabetes 23:604–610. https://doi.org/10.1111/pedi.13368
doi: 10.1111/pedi.13368
pubmed: 35644029
Oyagüez I, Gómez-Peralta F, Artola S et al (2021) Cost analysis of FreeStyle Libre® 2 system in type 2 diabetes mellitus population. Diabetes Therapy 12:2329–2342. https://doi.org/10.1007/s13300-021-01064-4
doi: 10.1007/s13300-021-01064-4
pubmed: 33948909
pmcid: 8096131
Freckmann G (2020) Basics and use of continuous glucose monitoring (CGM) in diabetes therapy. J Labor Med 44:71–79. https://doi.org/10.1515/labmed-2019-0189
doi: 10.1515/labmed-2019-0189
Lorenz C, Sandoval W, Mortellaro M (2018) Interference assessment of various endogenous and exogenous substances on the performance of the eversense long-term implantable continuous glucose monitoring system. Diabetes Technol Ther 20:344–352. https://doi.org/10.1089/dia.2018.0028
doi: 10.1089/dia.2018.0028
pubmed: 29600877
pmcid: 5963543
Christiansen MP, Garg SK, Brazg R et al (2017) Accuracy of a fourth-generation subcutaneous continuous glucose sensor. Diabetes Technol Ther 19:446–456. https://doi.org/10.1089/dia.2017.0087
doi: 10.1089/dia.2017.0087
pubmed: 28700272
pmcid: 5567873
Gildon BW (2018) InPen smart insulin pen system: product review and user experience. Diabetes Spectrum 31:354–358. https://doi.org/10.2337/ds18-0011
doi: 10.2337/ds18-0011
pubmed: 30510392
pmcid: 6243223
Rayman G, Kröger J, Bolinder J (2018) Could FreeStyle LibreTM sensor glucose data support decisions for safe driving? Diabet Med 35:491–494. https://doi.org/10.1111/dme.13515
doi: 10.1111/dme.13515
pubmed: 28945936
Hoss U, Budiman ES (2017) Factory-calibrated continuous glucose sensors: the science behind the technology. Diabetes Technol Ther 19:S-44-S−50. https://doi.org/10.1089/dia.2017.0025
doi: 10.1089/dia.2017.0025
Ramadoss P, Rahman MI, Perumal A et al (2020) Non-invasive, non-enzymatic, biodegradable and flexible sweat glucose sensor and its electrochemical studies. ChemistrySelect 5:11305–11321. https://doi.org/10.1002/slct.202002622
doi: 10.1002/slct.202002622
Yao Y, Chen J, Guo Y et al (2021) Integration of interstitial fluid extraction and glucose detection in one device for wearable non-invasive blood glucose sensors. Biosens Bioelectron 179:113078. https://doi.org/10.1016/j.bios.2021.113078
doi: 10.1016/j.bios.2021.113078
pubmed: 33607417
Kim J, Campbell AS, Wang J (2018) Wearable non-invasive epidermal glucose sensors: A review. Talanta 177:163–170. https://doi.org/10.1016/j.talanta.2017.08.077
doi: 10.1016/j.talanta.2017.08.077
pubmed: 29108571
Lerner MB, Kybert N, Mendoza R et al (2013) Scalable, non-invasive glucose sensor based on boronic acid functionalized carbon nanotube transistors. Appl Phys Lett 102:183113. https://doi.org/10.1063/1.4804438
doi: 10.1063/1.4804438
Leelarathna L, Choudhary P, Wilmot EG et al (2021) Hybrid closed-loop therapy: Where are we in 2021? Diabetes Obes Metab 23:655–660. https://doi.org/10.1111/dom.14273
doi: 10.1111/dom.14273
pubmed: 33269551
Kim J, Campbell AS, de Ávila BE-F, Wang J (2019) Wearable biosensors for healthcare monitoring. Nat Biotechnol 37:389–406. https://doi.org/10.1038/s41587-019-0045-y
doi: 10.1038/s41587-019-0045-y
pubmed: 30804534
pmcid: 8183422
Baker LB, Wolfe AS (2020) Physiological mechanisms determining eccrine sweat composition. Eur J Appl Physiol 120:719–752. https://doi.org/10.1007/s00421-020-04323-7
doi: 10.1007/s00421-020-04323-7
pubmed: 32124007
pmcid: 7125257
Guk K, Han G, Lim J et al (2019) Evolution of wearable devices with real-time disease monitoring for personalized healthcare. Nanomaterials 9:813. https://doi.org/10.3390/nano9060813
doi: 10.3390/nano9060813
pubmed: 31146479
pmcid: 6631918
Christodouleas DC, Kaur B, Chorti P (2018) From point-of-care testing to eHealth diagnostic devices (eDiagnostics). ACS Cent Sci 4:1600–1616. https://doi.org/10.1021/acscentsci.8b00625
doi: 10.1021/acscentsci.8b00625
pubmed: 30648144
pmcid: 6311959
Padash M, Enz C, Carrara S (2020) Microfluidics by additive manufacturing for wearable biosensors: a review. Sensors 20:4236. https://doi.org/10.3390/s20154236
doi: 10.3390/s20154236
pubmed: 32751404
pmcid: 7435802
Yeo JC, Kenry LCT (2016) Emergence of microfluidic wearable technologies. Lab Chip 16:4082–4090. https://doi.org/10.1039/C6LC00926C
doi: 10.1039/C6LC00926C
pubmed: 27713996
Linz T, Kallmayer C, Aschenbrenner R, Reichl H (2005) Embroidering electrical interconnects with conductive yarn for the integration of flexible electronic modules into fabric. In: Ninth IEEE International Symposium on Wearable Computers (ISWC’05). IEEE 86–89
Savage S, Estacio RO, Jeffers B, Schrier RW (1996) Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 19:1243–1248
doi: 10.2337/diacare.19.11.1243
pubmed: 8908388
Dixon TA, Williams TC, Pretorius IS (2021) Sensing the future of bio-informational engineering. Nat Commun 12:388. https://doi.org/10.1038/s41467-020-20764-2
doi: 10.1038/s41467-020-20764-2
pubmed: 33452260
pmcid: 7810845
Tittl A, John-Herpin A, Leitis A et al (2019) Metaoberflächen-basierte molekulare Biosensorik unterstützt von künstlicher Intelligenz. Angew Chem 131:14952–14965. https://doi.org/10.1002/ange.201901443
doi: 10.1002/ange.201901443
Ma X, Ahadian S, Liu S et al (2021) Smart contact lenses for biosensing applications. Advanced Intelligent Systems 3:2000263. https://doi.org/10.1002/aisy.202000263
doi: 10.1002/aisy.202000263
Liao X, Song W, Zhang X et al (2020) A bioinspired analogous nerve towards artificial intelligence. Nat Commun 11:268. https://doi.org/10.1038/s41467-019-14214-x
doi: 10.1038/s41467-019-14214-x
pubmed: 31937777
pmcid: 6959309
Zhang J, Huang H, Song G et al (2022) Intelligent biosensing strategies for rapid detection in food safety: a review. Biosens Bioelectron 202:114003. https://doi.org/10.1016/j.bios.2022.114003
doi: 10.1016/j.bios.2022.114003
pubmed: 35065479
Zebda A, Cinquin P, Martin D (2021) Patent application: method for determining an actual concentration of substrate using an array of self-calibrated biosensors and device for implementing the method. Ref. WO 2021/250627 A1. (1–40)
Li W, Luo W, Li M, et al (2021) The impact of recent developments in electrochemical POC sensor for blood sugar care. Front Chem 9:723186. https://doi.org/10.3389/fchem.2021.723186
Teymourian H, Barfidokht A, Wang J (2020) Electrochemical glucose sensors in diabetes management: an updated review (2010–2020). Chem Soc Rev 49:7671–7709. https://doi.org/10.1039/d0cs00304b
doi: 10.1039/d0cs00304b
pubmed: 33020790
Hovorka R (2006) Continuous glucose monitoring and closed-loop systems. Diabet Med 23:1–12. https://doi.org/10.1111/j.1464-5491.2005.01672.x
doi: 10.1111/j.1464-5491.2005.01672.x
pubmed: 16409558
Breton M, Farret A, Bruttomesso D et al (2012) Fully integrated artificial pancreas in type 1 diabetes. Diabetes 61:2230–2237. https://doi.org/10.2337/db11-1445
doi: 10.2337/db11-1445
pubmed: 22688340
pmcid: 3425406
Boughton CK, Hovorka R (2019) Is an artificial pancreas (closed-loop system) for type 1 diabetes effective? Diabet Med 36:279–286. https://doi.org/10.1111/dme.13816
doi: 10.1111/dme.13816
pubmed: 30183096
Park JB, Song MS, Ghosh R et al (2021) Highly sensitive and flexible pressure sensors using position- and dimension-controlled ZnO nanotube arrays grown on graphene films. NPG Asia Mater 13:57. https://doi.org/10.1038/s41427-021-00324-w
doi: 10.1038/s41427-021-00324-w
Mohan AMV, Rajendran V, Mishra RK, Jayaraman M (2020) Recent advances and perspectives in sweat based wearable electrochemical sensors. TrAC Trends Anal Chem 131:116024. https://doi.org/10.1016/j.trac.2020.116024
doi: 10.1016/j.trac.2020.116024
Yeung KK, Huang T, Hua Y et al (2021) Recent advances in electrochemical sensors for wearable sweat monitoring: a review. IEEE Sens J 21:14522–14539. https://doi.org/10.1109/JSEN.2021.3074311
doi: 10.1109/JSEN.2021.3074311